A peptide with this many downstream targets carries a wider theoretical side-effect surface than one confined to adipose tissue lipolysis
This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such
The MHRA, in April 2026, has effectively made the same call
Okamoto T, Takahashi S, Nakamura E et al
Pharmacokinetic parameters after intravenous administration in rats showed Dihexa possessed a long half-life of 12.68 days and was extensively distributed, indicated by a large volume of distribution (Va)
Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites